18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors

390 Citationer (Scopus)

Abstract

(18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) is currently not used on a routine basis for imaging of neuroendocrine (NE) tumors. The aim of this study was to investigate the prognostic value of FDG-PET in patients with NE tumors.
OriginalsprogEngelsk
TidsskriftClinical Cancer Research
Vol/bind16
Udgave nummer3
Sider (fra-til)978-85
Antal sider8
ISSN1078-0432
DOI
StatusUdgivet - 1 feb. 2010

Fingeraftryk

Dyk ned i forskningsemnerne om '18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors'. Sammen danner de et unikt fingeraftryk.

Citationsformater